期刊
PHARMACEUTICS
卷 14, 期 3, 页码 -出版社
MDPI
DOI: 10.3390/pharmaceutics14030522
关键词
affibody molecule; human epidermal growth factor receptor 2; HER2; SKOV3; emtansine; DM1; albumin binding domain; affibody drug conjugate; AffiDC
资金
- Swedish Agency for Innovation VINNOVA [2019/00104]
- Swedish Cancer Society Cancerfonden [CAN 21 1861 Pj, 2020/181, 20 0893 Pj]
- China Scholarship Council (CSC)
- Vinnova [2019-00104] Funding Source: Vinnova
This study investigated the influence of linker length and composition on the functionality and biodistribution of targeted drug conjugates, finding that longer linkers decreased affinity to HER2 and serum albumin but reduced liver uptake. This provides important insights into molecular design for developing drug conjugates with reduced hepatic uptake.
Targeted drug conjugates based on Affibody molecules fused to an albumin-binding domain (ABD) for half-life extension have demonstrated potent anti-tumor activity in preclinical therapeutic studies. Furthermore, optimization of their molecular design might increase the cytotoxic effect on tumors and minimize systemic toxicity. This study aimed to investigate the influence of length and composition of a linker between the human epidermal growth factor receptor 2 (HER2)-targeted affibody molecule (Z(HER2:2891)) and the ABD domain on functionality and biodistribution of affibody-drug conjugates containing a microtubulin inhibitor mertansin (mcDM1) (AffiDCs). Two conjugates, having a trimeric (S(3)G)(3) linker or a trimeric (G(3)S)(3) linker were produced, radiolabeled with Tc-99m(CO)(3), and compared side-by-side in vitro and in vivo with the original Z(HER2:2891)-G(4)S-ABD-mcDM1 conjugate having a monomeric G(4)S linker. Both conjugates with longer linkers had a decreased affinity to HER2 and mouse and human serum albumin in vitro, however, no differences in blood retention were observed in NMRI mice up to 24 h post injection. The use of both (S(3)G)(3) and (G(3)S)(3) linkers reduced liver uptake of AffiDCs by approximately 1.2-fold compared with the use of a G(4)S linker. This finding provides important insights into the molecular design for the development of targeted drug conjugates with reduced hepatic uptake.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据